- Home
- ACXP vs SBFM Comparison
ACXP vs SBFM Comparison
Compare ACXP & SBFM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ACXP
- SBFM
- Stock Information
- Founded
- ACXP 2017
- SBFM 2006
- Country
- ACXP United States
- SBFM United States
- Employees
- ACXP N/A
- SBFM N/A
- Industry
- ACXP Biotechnology: Pharmaceutical Preparations
- SBFM Biotechnology: Pharmaceutical Preparations
- Sector
- ACXP Health Care
- SBFM Health Care
- Exchange
- ACXP Nasdaq
- SBFM Nasdaq
- Market Cap
- ACXP 6.8M
- SBFM 6.7M
- IPO Year
- ACXP 2021
- SBFM N/A
- Fundamental
- Price
- ACXP $4.24
- SBFM $1.67
- Analyst Decision
- ACXP Strong Buy
- SBFM Strong Buy
- Analyst Count
- ACXP 3
- SBFM 1
- Target Price
- ACXP $143.67
- SBFM $15.00
- AVG Volume (30 Days)
- ACXP 89.0K
- SBFM 62.2K
- Earning Date
- ACXP 11-12-2025
- SBFM 11-04-2025
- Dividend Yield
- ACXP N/A
- SBFM N/A
- EPS Growth
- ACXP N/A
- SBFM N/A
- EPS
- ACXP N/A
- SBFM N/A
- Revenue
- ACXP N/A
- SBFM $36,341,741.00
- Revenue This Year
- ACXP N/A
- SBFM $32.20
- Revenue Next Year
- ACXP N/A
- SBFM $32.74
- P/E Ratio
- ACXP N/A
- SBFM N/A
- Revenue Growth
- ACXP N/A
- SBFM 19.22
- 52 Week Low
- ACXP $3.80
- SBFM $1.17
- 52 Week High
- ACXP $43.20
- SBFM $3.90
- Technical
- Relative Strength Index (RSI)
- ACXP 51.39
- SBFM 67.82
- Support Level
- ACXP $3.97
- SBFM $1.50
- Resistance Level
- ACXP $4.85
- SBFM $1.67
- Average True Range (ATR)
- ACXP 0.35
- SBFM 0.08
- MACD
- ACXP -0.02
- SBFM 0.01
- Stochastic Oscillator
- ACXP 23.45
- SBFM 73.44
About ACXP Acurx Pharmaceuticals Inc.
Acurx Pharmaceuticals Inc is a clinical stage biopharmaceutical company developing a new class of antibiotics for infections caused by bacteria listed as priority pathogens by the World Health Organization, Centers for Disease Control and Prevention and Food and Drug Administration. The company's approach is to develop antibiotic candidates with a Gram-positive selective spectrum. The Company's segment consists of the development of clinical and preclinical product candidates for the development of the Company's proprietary new therapies.
About SBFM Sunshine Biopharma Inc.
Sunshine Biopharma Inc is a pharmaceutical company offering and researching life-saving medicines in a wide variety of therapeutic areas, including oncology and antivirals. Through its subsidiaries, the company has various generic prescription drugs on the market in Canada and is also involved in developing and selling OTC supplements. In addition, the company is conducting a proprietary drug development program, which is comprised of K1.1 mRNA targeted for liver cancer and SBFM-PL4, PLpro protease inhibitor for SARS Coronavirus infections.